MadeAi

Startup

MadeAi, Inc., provides MadeAi™, a purpose-built, award-winning AI platform for evidence synthesis in life sciences.
Serving HEOR, Medical Affairs, Market Access, and RWE teams at pharma manufacturers, medtech companies, and
CROs, MadeAi accelerates systematic literature reviews (SLRs), value dossiers, clinical evidence reports, and real-
world evidence generation. Its four-layer AI architecture, combining Retrieval, Structured Pipeline, LLM Reasoning,
and Human Adjudication, delivers results up to 60% faster with over 90% accuracy, while maintaining full regulatory
compliance, including SOC 2, HIPAA, and GxP-ready standards. Validated at ISPOR 2026 across four peer-reviewed
posters, MadeAi is the only end-to-end, submission-grade evidence operations platform built specifically for
regulated life sciences workflows.

website